Fei Song

发表

Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens

Fei Song, 2014 .

Middle East Respiratory Syndrome Coronavirus Spike Protein Delivered by Modified Vaccinia Virus Ankara Efficiently Induces Virus-Neutralizing Antibodies

G. Sutter, B. Haagmans, A. Osterhaus, 2013, Journal of Virology.

Induces Virus-Neutralizing Antibodies Modified Vaccinia Virus Ankara Efficiently Coronavirus Spike Protein Delivered by Middle East Respiratory Syndrome

B. Haagmans, S. Becker, A. Volz, 2014 .

Generation and characterization of mouse monoclonal antibodies against the VP4 protein of group A human rotaviruses.

W. Liu, Wei Liu, N. Xia, 2022, Antiviral research.

Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses

Han Yang, N. Xia, Jun Zhang, 2022, iScience.

Establishment of Sandwich ELISA for Quality Control in Rotavirus Vaccine Production

N. Xia, Yingbin Wang, Shiyin Zhang, 2022, Vaccines.

Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases

G. Rimmelzwaan, J. Kreijtz, G. Sutter, 2014, Viruses.

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

G. Sutter, M. Eickmann, S. Becker, 2015, Journal of Virology.

Protective efficacy of recombinant Modified Vaccinia virus Ankara (MVA) delivering

G. Sutter, M. Eickmann, S. Becker, 2015 .